Consumer face segment would benefit the most, given higher effective tax rates of over 30 per cent, while export-linked sectors such as IT and pharma will benefit the least, accounting for only 5-6 per cent of potential savings. That’s because they already enjoy low effective tax rates. 

Pennar Industries has informed the bourses on Tuesday that it has doubled its Cold Drawn Welded (CDW) tubes manufacturing capacity. Pennar is one of the leading suppliers of CDW tubes to India’s automotive and construction equipment sectors.

Shares of Suven Life Sciences jumped more than 4 per cent after the company announced dose administration of the first patient in a Phase 2A clinical trial of SUVN G-3031, a Histamine H3 receptor inverse agonist in a double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of 2 mg and 4 mg SUVN-G3031 compared to placebo in patients with narcolepsy with or without cataplexy.

Following stocks are close to their 52-weeks low as at 14:20 p.m. on September 24, 2019.

The markets on September 24, 2019 opened gap up. BSE Sensex is trading at 38,986.08, down by 103.95 points and the Nifty is trading at 11,559.60, down by 40.60 points. 

Financial literacy is must and it is important to pass it on to the next generation. Here are some of the money values that you can teach your children.

Wipro announced on Monday that it has successfully launched the first phase of noomis, the new platform of FEBRABAN.

The announcement of Hon’ble Finance Minister regarding tax on buy back of listed companies saved buyback tax of many companies including Star Cement.

On Monday, when the indices were touching roof on account of cut in corporate tax, the stock of ZEE Entertainment (ZEEL) was bleeding red as lenders to the Essel group sold pledged promoters’ shares of ZEEL. As per media reports, it is SBI Mutual fund which invoked pledged shares in the company.

Biocon’s subsidiary, Biocon Biologics has acquired R&D capital assets for 60,000 sq. ft. state-of-the-art ‘bench to pilot scale’ Biologics research facility at TICEL Bio Park in Chennai, India.